• Strategy
  • Portfolio
  • People
  • Careers
  • News
  • Blog
  • Contact Us
Foresite News
Press Releases
Portfolio News

For press inquiries click here to contact us.

Candid Therapeutics

With $370M debut, Candid Therapeutics is upfront about goal to lead a coming T-cell engager wave

September 9, 2024
Avenzo Therapeutics

Avenzo and Gilead partner for breast cancer combination regimen trial

September 4, 2024
Element Biosciences

Element Biosciences nets $277M ahead of new sequencer launch

July 12, 2024
Kinnate Biopharma

Kinnate Biopharma Inc. Enters into Agreement to be Acquired by XOMA Corporation for Between $2.3352 and $2.5879 Per Share in Cash, Plus One Contingent Value Right per Share

April 30, 2024
Xaira Therapeutics

Exclusive: In $1B+ bet on AI, biopharma heavyweights back new startup to upend drug R&D

April 23, 2024
Alumis, Inc.

Alumis closes $259M series C in year’s largest private biotech fundraise yet

March 6, 2024
Thyme Care

This Startup Just Raised $60 Million To Help Cancer Patients Navigate Their Care

August 21, 2023
CG Oncology

CG Oncology reels in $105M crossover for potential late 2024 bladder cancer drug filing

August 2, 2023
Everly Health

Scoop: Everly partnership to offer home cancer tests to health plan

February 3, 2023
Remix Therapeutics

Is there room for a new way to drug RNA? ARCH, Foresite join Atlas, The Column Group for $81M bet

September 28, 2022
Page 3 of 25«12345...1020...»Last »

Please see important disclaimers in the Terms section.


©2022 Foresite Capital Management, LLC. Site by GOODLAB

    • Strategy
    • Portfolio
    • People
    • Careers
    • News
    • Blog
    • Contact Us
    • Contact Us
    • Foresite Labs
    • Investor Login
    • Terms
    • Privacy Policy
    Close
    • News
    • Blog
    • Foresite Labs
    • Contact Us
    • Home
    • Strategy
    • Portfolio
    • People
    • Careers
    • News
    • Blog
    • Contact Us
    • Foresite Labs
    • Investor Login
    • Terms
    • Privacy Policy
      • Blog
      • Careers
      • Contact Us
      • Disclosures
      • Home
      • Legal Disclaimers
      • Pardes Biosciences Legend
      • Privacy Policy
      • Strategy
      • Terms

    ©2025 Foresite Capital Management, LLC.

    Site by Goodlab

    Close